tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
Advertisement

Tvardi Therapeutics (TVRD) Income Statement

Compare
2,482 Followers

Tvardi Therapeutics Income Statement

Last quarter (Q2 2025), Tvardi Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Tvardi Therapeutics's net income was $4.17M. See Tvardi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.14M$ 20.97M$ 41.87M$ 23.03M$ 135.08M
Gross Profit
$ 6.33M$ 14.54M$ 34.35M$ 21.47M$ 0.00
Operating Expenses
$ 62.11M$ 18.66M$ 21.19M$ 110.56M$ 128.68M
Depreciation and Amortization
$ 192.00K$ 95.00K$ 85.00K$ 1.55M$ 1.01M
EBITDA
$ -62.60M$ -17.25M$ -20.45M$ -86.89M$ 8.73M
Operating Income
$ -55.78M$ -18.66M$ -21.19M$ -89.08M$ 5.38M
Other Income/Expenses
$ -15.48M$ 1.32M$ 651.00K$ 642.00K$ 2.33M
Pretax Income
$ -71.27M$ -17.35M$ -20.54M$ -88.44M$ 7.72M
Net Income
$ -70.87M$ -17.35M$ -20.54M$ -88.44M$ 8.41M
Per Share Metrics
Basic EPS
$ -46.59$ -1.85$ -2.20$ -62.77$ 6.39
Diluted EPS
$ -46.59$ -1.85$ -2.20$ -62.77$ 6.32
Weighted Average Shares Outstanding
1.52M 9.36M 9.36M 1.41M 1.32M
Weighted Average Shares Outstanding (Diluted)
1.52M 9.36M 9.36M 1.41M 1.33M
Currency in USD

Tvardi Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis